Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 114 clinical trials
A Real World Study of Camrelizumab in the Treatment of Advanced Non-squamous Non-small-cell Lung Cancer

To provide sufficient scientific evidence for rational drug use of camrelizumab in the treatment of advanced non-squamous non-small cell lung cancer in China, efficacy,safety and cost

lung cancer
cancer
EGFR
lung carcinoma
  • 0 views
  • 05 Jun, 2022
  • 1 location
LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic BiomarKers in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (LIQUIK)

metastatic non-squamous Non-small Cell Lung Cancer (NSCLC), amongst other endpoints.

HER2
non-squamous non-small cell lung cancer
targeted therapy
systemic therapy
adjuvant chemotherapy
  • 0 views
  • 30 Jun, 2022
  • 6 locations
Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity

This study evaluates gut microbiome and functional status as modifiable biomarkers in predicting immunotherapy response and toxicity in patients with stage IV non-squamous non-small cell lung

  • 0 views
  • 05 Aug, 2021
  • 1 location
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

This study aims to explore the efficacy and safety of Erlotinib/Gefitinib combined with bevacizumab in the real world for advanced non-squamous cell lung cancer with EGFR mutation, explore new drug resistance mechanisms under the A+T regimen and consistency between plasma and tissue detection driving genes, and finally assess the predictive …

lung carcinoma
gefitinib
EGFR
bevacizumab
erlotinib
  • 6 views
  • 14 Mar, 2022
  • 1 location